Polyoxazoline-Drug Conjugates With Tunable Release Through Conformation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing polymer conjugate technologies lack the ability to control the release rate and profile of agents, such as drugs, leading to variable and undesirable pharmacokinetic effects.
Innovation Solution
The conformation of the polyoxazoline (POZ) conjugate is modulated by altering characteristics like polymer size, agent nature, and loading percentage to control the release rate and profile of agents through physiologically degradable linkages, influencing the accessibility of cleaving functions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If drugs are attached as pendent groups along the polymer backbone for release after administration, then drug delivery is achieved, but the release rate is variable and difficult to control
Solution Approach 1:
The patent applies parameter changes by systematically varying polymer characteristics (molecular weight, composition, architecture) and linkage properties (chemical structure, degradation rate) to precisely control the release rate and profile of drugs from POZ conjugates, transforming the variable release behavior into a controllable parameter
2Object-affected harmful factors
If slow/sustained release of agent is implemented, then local adverse effects are reduced and half-life is extended, but dosing flexibility is reduced
Solution Approach 1:
The patent implements dynamics by creating polymer conjugate systems where the release rate can be dynamically adjusted through modifications to polymer structure and linkage chemistry, enabling the system to adapt between sustained release and faster release profiles depending on therapeutic requirements
3Speed
If fast/immediate release of agent is implemented, then high concentrations are achieved quickly, but peak blood level adverse effects increase
Solution Approach 1:
The patent uses parameter changes to control the degradation rate of linkages and the architecture of polymer conjugates, enabling precise adjustment of release speed to achieve rapid drug delivery while avoiding excessive peak concentrations that cause adverse effects
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for tailored release profiles, reducing local adverse effects, extending agent half-life, and achieving desired concentration levels, enhancing therapeutic efficacy and patient compliance.
Implementation Method 1
The agent is linked to the POZ polymer through a physiologically degradable linkage. Cleavage of the physiologically degradable linkage may be controlled by altering the conformation of the POZ conjugate to increase or decrease access of a cleaving function (for example, an enzyme) to the physiologically degradable linkage.
Data Source
AI summary
Polyoxazoline (POZ) conjugates wherein the conformation of the POZ conjugate and the release rate of an agent from the POZ conjugate can be controlled by selecting one or more characteristics of the POZ polymer and methods of controlling the conformation of a POZ conjugate and the release rate of an agent prior are provided as well as methods of treatment using such POZ conjugates and methods. Pharmaceutical compositions including a POZ conjugate are also provided.